SNYDER CAPITAL MANAGEMENT L P - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 220 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
SNYDER CAPITAL MANAGEMENT L P ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$16,916,000
-28.9%
150,376
-2.4%
0.43%
-25.0%
Q4 2021$23,791,000
+34.5%
154,026
+21.3%
0.58%
+22.9%
Q3 2021$17,685,000
+5.2%
126,941
-0.9%
0.47%
-0.4%
Q2 2021$16,811,000
+37.0%
128,140
+59.2%
0.47%
+33.1%
Q1 2021$12,272,000
-34.5%
80,500
-57.3%
0.35%
-42.4%
Q4 2020$18,727,000
+13.6%
188,306
+8.9%
0.61%
-13.2%
Q3 2020$16,481,000
-14.9%
172,906
-0.1%
0.71%
-19.5%
Q2 2020$19,365,000
+55.4%
173,132
+1.1%
0.88%
+23.7%
Q1 2020$12,458,000171,3150.71%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders